C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/62 (2006.01) A61K 39/395 (2006.01) C07K 14/11 (2006.01) C07K 16/00 (2006.01) C07K 16/10 (2006.01) C07K 16/20 (2006.01) C07K 19/00 (2006.01) C12N 15/13 (2006.01) C12N 15/44 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2163125
This invention relates to the introduction of oligopeptide epitopes of influenza virus nucleoprotein for expressing within the three dimensional fold of an immunoglobulin (Ig) molecule, thus creating molecules useful to induce specific, biologically active anti-viral immunity.
L'invention concerne l'introduction d'épitopes oligopeptidiques de la nucléoprotéine du virus de la grippe de manière à provoquer leur expression dans le repli tridimensionnel d'une molécule d'immunoglobuline (Ig) et à produire des molécules utilisées pour induire une immunité antivirale spécifique biologiquement active.
Billetta Rosario
Zanetti Maurizio
Smart & Biggar
The Regents Of The University Of California
LandOfFree
Genetically engineered immunoglobulins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genetically engineered immunoglobulins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetically engineered immunoglobulins will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1815298